- Home
- LPTH vs APLT Comparison
LPTH vs APLT Comparison
Compare LPTH & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPTH
- APLT
- Stock Information
- Founded
- LPTH 1985
- APLT 2016
- Country
- LPTH United States
- APLT United States
- Employees
- LPTH N/A
- APLT N/A
- Industry
- LPTH Semiconductors
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- LPTH Technology
- APLT Health Care
- Exchange
- LPTH Nasdaq
- APLT Nasdaq
- Market Cap
- LPTH 81.1M
- APLT 80.3M
- IPO Year
- LPTH 1996
- APLT 2019
- Fundamental
- Price
- LPTH $2.01
- APLT $0.44
- Analyst Decision
- LPTH Strong Buy
- APLT Buy
- Analyst Count
- LPTH 3
- APLT 7
- Target Price
- LPTH $4.67
- APLT $6.10
- AVG Volume (30 Days)
- LPTH 119.3K
- APLT 1.6M
- Earning Date
- LPTH 05-08-2025
- APLT 05-08-2025
- Dividend Yield
- LPTH N/A
- APLT N/A
- EPS Growth
- LPTH N/A
- APLT N/A
- EPS
- LPTH N/A
- APLT N/A
- Revenue
- LPTH $32,158,517.00
- APLT N/A
- Revenue This Year
- LPTH $16.90
- APLT N/A
- Revenue Next Year
- LPTH $52.77
- APLT $2,426.33
- P/E Ratio
- LPTH N/A
- APLT N/A
- Revenue Growth
- LPTH N/A
- APLT N/A
- 52 Week Low
- LPTH $1.04
- APLT $0.43
- 52 Week High
- LPTH $4.42
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- LPTH 39.17
- APLT 35.66
- Support Level
- LPTH $2.03
- APLT $0.45
- Resistance Level
- LPTH $2.23
- APLT $0.56
- Average True Range (ATR)
- LPTH 0.16
- APLT 0.05
- MACD
- LPTH 0.01
- APLT 0.00
- Stochastic Oscillator
- LPTH 22.00
- APLT 3.24
About LPTH LightPath Technologies Inc.
LightPath Technologies Inc is a manufacturer, distributor, and integrator of proprietary optical components and assemblies. It is also engaged in the research and development for optical solutions for the traditional optics markets and communications markets. The company's business based on the following product groups: precision molded optics, specialty products, and infrared products. It currently serves the following major markets, distribution and catalog, laser, industrial, instrumentation, telecommunications, and defense.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.